- Home
- EXLS vs CORT Comparison
EXLS vs CORT Comparison
Compare EXLS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXLS
- CORT
- Stock Information
- Founded
- EXLS 1999
- CORT 1998
- Country
- EXLS United States
- CORT United States
- Employees
- EXLS N/A
- CORT N/A
- Industry
- EXLS Business Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- EXLS Consumer Discretionary
- CORT Health Care
- Exchange
- EXLS Nasdaq
- CORT Nasdaq
- Market Cap
- EXLS 7.1B
- CORT 7.5B
- IPO Year
- EXLS 2006
- CORT N/A
- Fundamental
- Price
- EXLS $45.27
- CORT $72.98
- Analyst Decision
- EXLS Strong Buy
- CORT Strong Buy
- Analyst Count
- EXLS 7
- CORT 4
- Target Price
- EXLS $49.57
- CORT $142.00
- AVG Volume (30 Days)
- EXLS 3.3M
- CORT 1.6M
- Earning Date
- EXLS 07-31-2025
- CORT 07-28-2025
- Dividend Yield
- EXLS N/A
- CORT N/A
- EPS Growth
- EXLS 21.21
- CORT 8.36
- EPS
- EXLS 1.32
- CORT 1.14
- Revenue
- EXLS $1,902,884,000.00
- CORT $685,446,000.00
- Revenue This Year
- EXLS $14.18
- CORT $35.83
- Revenue Next Year
- EXLS $11.53
- CORT $35.24
- P/E Ratio
- EXLS $34.28
- CORT $63.26
- Revenue Growth
- EXLS 14.18
- CORT 30.93
- 52 Week Low
- EXLS $31.02
- CORT $29.42
- 52 Week High
- EXLS $52.43
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- EXLS 48.84
- CORT 49.68
- Support Level
- EXLS $43.73
- CORT $68.52
- Resistance Level
- EXLS $45.55
- CORT $75.95
- Average True Range (ATR)
- EXLS 1.27
- CORT 2.66
- MACD
- EXLS -0.09
- CORT -0.13
- Stochastic Oscillator
- EXLS 40.22
- CORT 42.13
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.